Dr. Akram Mesleh Shayeb, MD

Dr. Mesleh Shayeb practices at Providence St. Joseph Hospital Eureka in Eureka, California, part of Providence Health & Services.

Dr. Mesleh Shayeb's NPI, 1861784993, was assigned on May 9, 2011. Dr. Mesleh Shayeb graduated from University of Puerto Rico, Medical Sciences Campus in 2011. Dr. Mesleh Shayeb's California license number on file is A154825.

Dr. Mesleh Shayeb's primary practice is Providence St. Joseph Hospital Eureka, at 2700 Dolbeer St, Eureka, CA 95501 in Humboldt County. The practice phone is (707) 445-8121.

Dr. Mesleh Shayeb's primary practice is Providence St. Joseph Hospital Eureka in Eureka, California, part of Providence Health & Services. Dr. Mesleh Shayeb is also affiliated with Aspirus Rhinelander Hospital. The medical group on file is St. Jude Heritage Medical Group. Dmand AI also links Dr. Mesleh Shayeb to 3 more hospitals, 2 medical groups, 1 group practice or clinic, 1 home health agency and 1 rural health clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mesleh Shayeb practices, 8 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Mesleh Shayeb's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Mesleh Shayeb is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Mesleh Shayeb's licenses on file in 3 states: California, Hawaii and Tennessee.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, colorectal cancer, immune deficiency disease, lung cancer, lymphoma and multiple myeloma among the conditions Dr. Mesleh Shayeb treats.

CMS data shows 1,315 Medicare services from Dr. Mesleh Shayeb across 3 procedure codes in 2024, all of them office visits, for 405 Medicare patients. Medicare paid $127,031 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 405 Medicare patients who saw Dr. Mesleh Shayeb in 2024. The largest group is 65 to 74, with 208 patients. 70% of them have high blood pressure, and 61% have high cholesterol. 31% are also on Medicaid. Their average risk score is 2.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mesleh Shayeb's median patient age at 73, with 50% women.

In 2024, Dr. Mesleh Shayeb wrote 1,704 Medicare Part D claims for 228 patients. 83% of them were for generic drugs. CMS names the drug for 1,430 of them, across 44 drugs with 11 or more claims each, at $3,347,708 in total drug cost. In 2023, CMS named 777 claims across 28 drugs.

Dr. Mesleh Shayeb accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mesleh Shayeb as offering telehealth.

Dmand AI links 3 papers to Dr. Mesleh Shayeb, published from 2018 to 2021. Dr. Mesleh Shayeb's most frequent co-authors are Lama Ma Elbahlawan, MD, Jeremie Heath Estepp, MD and Sue C. Kaste, DO.

CMS Open Payments shows 31 general payments to Dr. Mesleh Shayeb from 17 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 53% of the total. CSL Behring paid the most, $2,500.

Dr. Mesleh Shayeb graduated from University of Puerto Rico, Medical Sciences Campus in 2011.

Dr. Mesleh Shayeb is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.